COMPASS FINANCIAL MANAGEMENT LLC’s Sana Biotechnology SANA Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.82K	Buy	+1,095	New	+$3.53K	﹤0.01%	1228

Other funds holding SANA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's SANA Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Sana Biotechnology (SANA) in Q2 2026: 1,095 shares worth $3.82K. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings.

119 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 1,095 shares of Sana Biotechnology worth $3.82K as of Q2 2026.
Sana Biotechnology was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Sana Biotechnology made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1228 holding.
119 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.